NCT02971501 2026-03-17
Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
University of Washington
Roswell Park Cancer Institute
University of Washington
National Cancer Institute (NCI)
Northwestern University
Emory University
University of Washington
Barbara Ann Karmanos Cancer Institute